Rhinolight treatment course Welcome

Welcome to the collective.care Rhinolight treatment course

collective.care is committed to providing accessible allergy health care to all Australians.

As part of this commitment is our interest in improving access to new medical technologies and treatments like Rhinolight.

Rhinolight has been shown in a number of studies to be safe and effective for persistent allergic rhinitis.

Our doctors have considered your medical case and suggested that UV rhino-phototherapy course could be helpful for your condition.

The Doctors at collective.care and Australian Allergy Centre have pioneered a new digital marketing + research approach using a social media so we can provide UV phototherapy for allergic rhinitis to the community at no cost to patients who have medicare.

Enlisting in our Rhinolight Treatment campaign means you consent to:

* Receiving 8 Treatments as part of the medical treatment course with Rhinolight Uv Phototherapy given by our Allergy trained Doctors

* Completing the Patient Surveys at the beginning and end of the treatment course and comment on your treatment course

* Connect with us on social media and receive important updates and email reminders about your treatment course

To avoid complications of dryness and crusting we encourage the purchase of NOZ-OIL.


By enlisting in our Rhinolight treatment course you are consenting to the use of your survey data to assist us with our proposal to Medicare to see nasal phototherapy be provided as a Medicare rebateable treatment for the treatment of perennial allergic rhinitis

Good luck with your treatment course! Your doctor will be monitoring you through the treatment course and we will email your Keep Handy Rhinolight Treatment Guide with answers to frequently asked questions and medical troubleshooting soon.

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.